Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment

Transforming growth factor‐β (TGF‐β) and programmed death ligand 1 (PD‐L1) initiate signaling pathways with complementary, nonredundant immunosuppressive functions in the tumor microenvironment (TME). In the TME, dysregulated TGF‐β signaling suppresses antitumor immunity and promotes cancer fibrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulley, James L., Schlom, Jeffrey, Barcellos‐Hoff, Mary Helen, Wang, Xiao‐Jing, Seoane, Joan, Audhuy, Francois, Lan, Yan, Dussault, Isabelle, Moustakas, Aristidis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168966/
https://www.ncbi.nlm.nih.gov/pubmed/34854206
http://dx.doi.org/10.1002/1878-0261.13146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168966/
https://www.ncbi.nlm.nih.gov/pubmed/34854206
http://dx.doi.org/10.1002/1878-0261.13146

Ejemplares similares